CN101084221B - 喜树碱的立体有择法和晶型 - Google Patents

喜树碱的立体有择法和晶型 Download PDF

Info

Publication number
CN101084221B
CN101084221B CN2005800440829A CN200580044082A CN101084221B CN 101084221 B CN101084221 B CN 101084221B CN 2005800440829 A CN2005800440829 A CN 2005800440829A CN 200580044082 A CN200580044082 A CN 200580044082A CN 101084221 B CN101084221 B CN 101084221B
Authority
CN
China
Prior art keywords
camptothecin
composition
acetal
gimatecan
camptothecine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN2005800440829A
Other languages
English (en)
Chinese (zh)
Other versions
CN101084221A (zh
Inventor
P·卡米纳蒂
M·O·廷蒂
M·马尔齐
F·乔吉
W·卡布里
M·阿尔珀加尼
D·弗加尼
P·格蒂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of CN101084221A publication Critical patent/CN101084221A/zh
Application granted granted Critical
Publication of CN101084221B publication Critical patent/CN101084221B/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
CN2005800440829A 2004-12-21 2005-12-16 喜树碱的立体有择法和晶型 Expired - Lifetime CN101084221B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04030246 2004-12-21
EP04030246.5 2004-12-21
PCT/EP2005/056849 WO2006067092A2 (en) 2004-12-21 2005-12-16 Stereoselective process and crystalline forms of a camptothecin

Publications (2)

Publication Number Publication Date
CN101084221A CN101084221A (zh) 2007-12-05
CN101084221B true CN101084221B (zh) 2011-05-11

Family

ID=34927884

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800440829A Expired - Lifetime CN101084221B (zh) 2004-12-21 2005-12-16 喜树碱的立体有择法和晶型

Country Status (18)

Country Link
US (3) US7799921B2 (enExample)
EP (1) EP1828196B1 (enExample)
JP (2) JP5491699B2 (enExample)
KR (1) KR101355121B1 (enExample)
CN (1) CN101084221B (enExample)
AU (1) AU2005318227B2 (enExample)
BR (1) BRPI0515832A (enExample)
CA (1) CA2590756C (enExample)
CY (1) CY1117243T1 (enExample)
DK (1) DK1828196T3 (enExample)
ES (1) ES2395930T3 (enExample)
HR (1) HRP20120926T1 (enExample)
ME (1) ME01495B (enExample)
PL (1) PL1828196T3 (enExample)
PT (1) PT1828196E (enExample)
RS (1) RS52585B (enExample)
SI (1) SI1828196T1 (enExample)
WO (1) WO2006067092A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1828196B1 (en) * 2004-12-21 2012-10-17 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Stereoselective process and crystalline forms of a camptothecin
ITRM20050418A1 (it) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.
FR2938534B1 (fr) 2008-11-14 2012-10-26 Sanofi Aventis Procede de preparation de l'hemifumarate d'eplivanserine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1044977A1 (en) * 1999-03-09 2000-10-18 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Camptothecin derivatives having antitumor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03271278A (ja) * 1990-03-16 1991-12-03 Nissan Chem Ind Ltd ２―アニリノピリミジン誘導体および農園芸用殺菌剤
JP3046401B2 (ja) * 1991-06-18 2000-05-29 イハラケミカル工業株式会社 ６−〔１−（ｎ−アルコキシイミノ）エチル〕サリチル酸誘導体及びその製造法
IL106786A (en) * 1992-09-10 1997-02-18 Basf Ag Substituted pyridine derivatives and fungicidal compositions containing them
AU2003215594A1 (en) * 2002-03-01 2003-09-16 Pharmacia Italia S.P.A. Crystalline polymorphic form of irinotecan hydrochloride
EP1828196B1 (en) * 2004-12-21 2012-10-17 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Stereoselective process and crystalline forms of a camptothecin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1044977A1 (en) * 1999-03-09 2000-10-18 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Camptothecin derivatives having antitumor activity

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Sabrina Dallavalle et al.Novel 7-oxyiminomethyl derivatives ofcamptothecinwithpotent in vitro and in vivo antitumor activity.Journal of Medicinal Chemistry44 20.2001,44(20),3264-3274.
Sabrina Dallavalle et al.Novel 7-oxyiminomethyl derivatives ofcamptothecinwithpotent in vitro and in vivo antitumor activity.Journal of Medicinal Chemistry44 20.2001,44(20),3264-3274. *
实施例2,说明书第10页第1-8行.

Also Published As

Publication number Publication date
US20100311783A1 (en) 2010-12-09
HK1113487A1 (en) 2008-10-03
WO2006067092A3 (en) 2006-11-02
EP1828196A2 (en) 2007-09-05
RS52585B (sr) 2013-04-30
US7799921B2 (en) 2010-09-21
PL1828196T3 (pl) 2013-02-28
AU2005318227A1 (en) 2006-06-29
EP1828196B1 (en) 2012-10-17
ES2395930T3 (es) 2013-02-18
KR101355121B1 (ko) 2014-01-24
JP5982261B2 (ja) 2016-08-31
CN101084221A (zh) 2007-12-05
US8124769B2 (en) 2012-02-28
PT1828196E (pt) 2012-11-19
KR20070097535A (ko) 2007-10-04
CY1117243T1 (el) 2017-04-05
US20090239893A1 (en) 2009-09-24
JP2013067629A (ja) 2013-04-18
ME01495B (me) 2014-04-20
DK1828196T3 (da) 2012-11-26
BRPI0515832A (pt) 2008-08-05
CA2590756C (en) 2014-09-02
US20100311784A1 (en) 2010-12-09
JP5491699B2 (ja) 2014-05-14
JP2008524306A (ja) 2008-07-10
CA2590756A1 (en) 2006-06-29
WO2006067092A2 (en) 2006-06-29
HRP20120926T1 (hr) 2012-12-31
SI1828196T1 (sl) 2012-12-31
AU2005318227B2 (en) 2011-08-18
US8101758B2 (en) 2012-01-24

Similar Documents

Publication Publication Date Title
US6194579B1 (en) Highly lipophilic camptothecin derivatives
CN101495486B (zh) 具有抗肿瘤活性的喜树碱衍生物
JP5982261B2 (ja) 立体選択的方法およびカンプトテシンの結晶形態
WO1996041806A1 (en) Novel water-soluble fluoroethylcamptothecin derivative and process for production thereof
JP5313895B2 (ja) 抗腫瘍活性を有するカンプトテシン誘導体
JP4791355B2 (ja) 抗腫瘍活性を有するカンプトテシンの７−イミノ誘導体
JP4477510B2 (ja) １０−ヒドロキシ−４−（ｓ）カンプトテンシンからトポテカンを調製する方法
KR20080068052A (ko) 신규의 결정형
HK1113487B (en) Stereoselective process and crystalline forms of a camptothecin
US6660861B1 (en) Process for preparing Topotecan from 10-hydroxy-4-(S) camptothecin
PL188075B1 (pl) Rozpuszczalne w wodzie C-pierścieniowe analogi 20(S)-kamptotecyny, kompozycja farmaceutyczna zawierająca te związki, ich zastosowanie oraz sposób wytwarzania
MX2007007258A (en) Stereoselective process and crystalline forms of a camptothecin
HK1089160B (en) 7-imino derivatives of camptothecin having antitumor activity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1113487

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1113487

Country of ref document: HK